Theoritin MF, tablets 4 mg 10 pcs

Pharmacotherapeutic group: Antiallergic agent – H1-histamine receptor blocker

ATX code: R06AX

Pharmacological properties.

Indications

Symptomatic treatment – chronic idiopathic urticaria, seasonal allergic rhinitis.

Pharmacological effect

Pharmacotherapeutic group: Antiallergic agent – ​​H1-histamine receptor blocker

ATX code: R06AX

Pharmacological properties

Special instructions

Caution should be exercised when using the drug in elderly patients, patients with angle-closure glaucoma and prostatic hyperplasia.

Active ingredient

Benzhydrylpiperazinylbutylmethylxanthine succinate

Composition

Active ingredient:

Benzhydrylpiperazinylbutylmethylxanthine succinate (teoritin) in terms of 100% substance – 4 mg,

Excipients:

Microcrystalline cellulose – 149.6 mg,

Sodium carboxymethyl starch – 4.8 mg,

Calcium stearate – 1.6 mg.

Pregnancy

The use of Teoritin® MF is contraindicated during pregnancy and breastfeeding.

Contraindications

Hypersensitivity to the active substance or any other component of the drug.
pregnancy and breastfeeding;
children under 18 years of age.
renal, liver failure
With caution:
Angle-closure glaucoma, prostatic hyperplasia.
Old age.

Side Effects

Almost all adverse events identified during clinical trials were of mild severity. There were no cases of serious adverse events; the identified adverse events were clinically insignificant and did not require any corrective measures.

The following are the adverse reactions observed in clinical studies, indicating the frequency of their development in accordance with the World Health Organization (WHO) classification: very common (≥1/10), common (≥1/100, <1/10), uncommon (≥1/1000, <1/100), rare (≥1/10000, <1/1000) and very rare (< 1/10000), frequency unknown (it was not possible to determine the frequency of occurrence based on available data). Disorders of the cardiovascular system: very rarely (isolated cases) - decreased heart rate (HR), increased heart rate.

Gastrointestinal disorders: often – dry mouth; very rarely (single case) – dyspepsia, abdominal pain.

Central nervous system disorders: often – headache; very rarely (single case) – dizziness, weakness.

Renal and urinary tract disorders: very rarely (single case) – dysuria.

Impact on the results of laboratory and instrumental studies: often – increased activity of “liver” transaminases and bilirubin levels; rarely – bilirubinuria, proteinuria; very rarely – an increase in urine pH, a change in glycemia levels (increase or decrease).

ECG: infrequently – disturbance of repolarization processes; very rarely – conduction disturbance.

If any of the side effects indicated in the instructions get worse or you notice other side effects not listed in the instructions, be sure to tell your doctor!

Interaction

Clinical studies did not reveal clinically significant interactions with other drugs. Eating does not affect the effectiveness of Teoritin® MF.

Overdose

During clinical studies, no cases of overdose were described when taking 4 mg of the drug per day for 14 days.

Treatment: in case of overdose, consult a doctor. Symptomatic treatment and gastric lavage are recommended. There is no specific antidote.

Storage conditions

In original packaging, at a temperature not exceeding 30 °C.
Keep out of the reach of children.

Shelf life

3 years.

Manufacturer

Obninsk HFC, Russia